INFORMATION
-
-
- 11/12/2019
- PRESS RELEASE
- FY2020/3 H1, Supplementary Material(Apr.1 to Sep.30 2019)
-
- 11/12/2019
- PRESS RELEASE
- FY2020/3 H1, Presentation (Apr.1 to Sep.30 2019)
-
- 09/30/2019
- PRESS RELEASE
- EISAI AND NICHI-IKO ENTER INTO COLLABORATION AGREEMENT FOR GENERIC PHARMACEUTICAL BUSINESS IN CHINA
-
- 09/11/2019
- PRESS RELEASE
- Consolidated Financial Results for the First Quarter of the Fiscal Year Ending March 31, 2020 (IFRS)
-
- 09/05/2019
- PRESS RELEASE
- Sagent Pharmaceuticals Announces FDA Acceptance of Omega Manufacturing Site
-
